The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

Please provide your email address to receive an email when new articles are posted on . The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and ...

When developing new therapies for diseases, biotech researchers are often limited by two time-consuming steps: first, screening thousands of drug candidates in test tubes and second, taking the best ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with human-based methods. The agency said the new approach will aim to improve drug ...

In a roadmap to change animal testing requirements for INDs, the U.S. FDA said its new approach will improve drug safety, hasten the evaluation process, and lower costs for companies and patients.

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...

95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind ...

Feinberg Professor emerita Eva Redei’s research had two key components: vats of water and “depressed” rats. Redei found that the rodents, genetically engineered in a Kyoto lab to exhibit depressive ...

WASHINGTON, D.C. – BROOKLYN/STATEN ISLAND Rep. Nicole Malliotakis (R-NY-11) last week introduced legislation in Congress that would ban most animal testing in federal labs, named the Safeguard Pets, ...